ABONIKI

Active ingredients

The drug ABONIKI contains a combination of these active pharmaceutical ingredients (APIs):

UNII LAV5U5022Y - METHYL SALICYLATE

Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.

Read about Methyl salicylate

2 Menthol

UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM

Read about Menthol

3 Camphora

UNII 213N3S8275 - CAMPHOR, (-)-

Read about Camphora

4 Eucalyptus oil

UNII 2R04ONI662 - EUCALYPTUS OIL

When the vapour is inhaled eucalyptus oil acts to ventilate the bronchial passages and relieve bronchitis and associated conditions. It is also a rubefacient.

Read about Eucalyptus oil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

M02AC

Preparations with salicylic acid derivatives

M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain

Discover more medicines within M02AC

Authorization and marketing

This brand name is authorized in the following countries: Nigeria

This drug has been assigned below unique identifiers within the countries it is being marketed:

Registered Drug Product Database

Identifier(s): 04-5773